kathimerini.gr
ELPEN Expands into Middle East Market
Greek pharmaceutical company ELPEN expands into the Middle East by establishing a subsidiary in Dubai, driven by market growth and a strategic focus on direct market access.
Greek
Greece
HealthInvestmentGrowthPharmaceuticalsInternational BusinessMarket Expansion
ElpenElpen Pharma Gmbh
Lefteris Tryphon
- Why did ELPEN establish a subsidiary in Dubai?
- ELPEN, a Greek pharmaceutical company, has established a subsidiary in Dubai, UAE, to expand its reach into the Middle East market.
- How does ELPEN's export success support its investment plans?
- The 155 million euro investment in research and production facilities in Eastern Attica and Tripoli is supported by the success of ELPEN's export activities.
- Describe ELPEN's strategy for international market penetration.
- ELPEN's strategic approach involves direct market access in dynamic regions, leveraging its innovative products, quality production, and expertise. This contrasts with utilizing representatives in some markets.
- What is the significance of exports to ELPEN's overall performance?
- The company's exports account for 60% of its profitability and 70% of its production. In the last two years, sales from markets outside of Greece have increased by 200%.
- What factors influenced ELPEN's decision to expand into the Middle East?
- ELPEN's expansion into the Middle East is driven by the region's growing market, preference for European products, and stable pricing and reimbursement framework.